SNRI – Swiss Neuro Radiology Institute

What SNRI – Swiss Neuro Radiology Institute does

SNRI – Swiss Neuro Radiology Institute is a privately held, specialized neuroradiology institute founded in 2020 and headquartered in Zürich, Switzerland, operating under the umbrella of the Swiss Clinical Neuro Sciences Institute (SCNSI). It provides diagnostic imaging and interventional neuroradiology services for brain and nervous system conditions, deploying a 3 Tesla SIEMENS Vida MRI and a SIEMENS Somatom go.top CT scanner for outpatient diagnostics at its Bürglistrasse 29 location, while performing inpatient interventional procedures — including aneurysm coiling, mechanical stroke recanalization, tinnitus therapy, stenting, and sclerotherapy — at Hirslanden Clinic (Witellikerstrasse 40). Adjacent offerings include a preventive brain check-up program (morphometry, functional analysis, vulnerability assessment), image-guided infiltrations, second opinion consultations, and a NIRS-based brain perfusion measurement capability (Luciole medical).

The institute serves two principal customer groups: individual patients accessing services through self-registration, online portals, or direct contact for brain check-ups and second opinions; and referring physicians — primarily general practitioners and neurologists — channeling patients for advanced diagnostics and image-guided treatments via a digital diagnostics and results portal (portal.snri.ch). Revenue is generated on a pay-as-you-go basis under the standardized Swiss Tarmed tariff system, with all Swiss insurance categories accepted; pricing is not publicly disclosed and quotes are provided upon consultation. The service model combines referral-led demand from the physician network with direct-to-consumer access through multilingual digital channels (German, English, French, Italian).

SNRI is clinically led by Prof. Dr. med. Isabel Wanke and Prof. Dr. med. Daniel Rüfenacht, both internationally recognized in diagnostic and interventional neuroradiology, and operates within a broader neuroscience ecosystem that includes the Swiss Neuro Radiosurgery Center (SNRC), Swiss Neuro & Headache Institute (SNHI), Zurich Epilepsy Institute, and Neurosono under SCNSI. The institute maintains research ties to the CABMM at the University of Zurich and to European bodies (ESMINT, EFMINT) co-founded by its leadership. No external equity funding, M&A activity, patents, or accreditations are disclosed in the available data; the team is small (approximately 6 staff) and operations are confined to the Zürich metropolitan area.

Name

SNRI – Swiss Neuro Radiology Institute

Legal name

SNRI – Swiss Neuro Radiology Institute

Website

https://snri.ch

Company type

Private

Operating status

Operating

Headcount range

1–10 employees

Short description

SNRI – Swiss Neuro Radiology Institute is a Zürich-based specialized neuroradiology institute providing diagnostic MRI/CT imaging and interventional procedures for brain and nervous system conditions, serving individual patients and referring physicians within the SCNSI network and Hirslanden Clinic.

Ownership category

akta.pro rank

Headquarters

HQ city

Zürich

HQ country

Switzerland

HQ region

Europe

Offices2 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Technology or R&D, Infrastructure, Operations, Marketing or Sales

Revenue model

1. Diagnostic Imaging Services: Outpatient neuroradiological diagnostics including MRI and CT scans. Revenue generated from imaging examinations using Tarmed tariffs (Swiss standard medical tariff system).
2. Neuroradiological Interventions: Inpatient diagnostic examinations and image-guided treatments including aneurysm coiling, stroke therapy, tinnitus therapy, stenting, and sclerotherapy performed at Hirslanden Clinic.
3. Brain Check-up Services: Comprehensive neuroradiological brain and vascular check-up packages including morphometry, functional analysis, and vulnerability assessment using MRI.
4. Second Opinion Consultations: Specialist consultation services for second opinions on neurovascular conditions including intracranial aneurysms, stroke risk, and other neurological matters.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels6 records

Core offering

SNRI is a specialized neuroradiology institute providing outpatient diagnostic imaging (MRI and CT), preventive brain and vascular check-up programs, and inpatient neurovascular interventions (aneurysm coiling, stroke therapy, tinnitus therapy, stenting, sclerotherapy) performed at Hirslanden Clinic. Services are delivered using a 3T SIEMENS Vida MRI, a SIEMENS Somatom go.top CT, and NIRS-based brain perfusion measurement, supported by a partner-oriented referral model with general practitioners and neurologists as well as direct patient self-registration.

Product overview

SNRI is a specialized neuroradiology institute offering a comprehensive portfolio of diagnostic imaging and interventional neuroradiology services. The core offerings include MRI and CT scanning services using state-of-the-art Siemens equipment, preventive brain check-up programs, and minimally invasive interventional procedures for neurovascular conditions including aneurysm treatment, stroke therapy, and tinnitus treatment. The institute also provides patient-facing digital platforms including an online registration system and diagnostic results portal for secure access to medical images and findings.

Differentiator

Problem solved

Functional benefit

Products and services

• Magnetic Resonance Imaging (MRI) Diagnostic MRI imaging using a 3T SIEMENS Vida system to produce highly detailed cross-sectional images of the brain and nervous system, including automated image processing and deep-learning capabilities for morphometry, functional analysis, and vessel assessment. Targeted at patients referred by GPs/neurologists and self-referring patients for brain and vascular diagnostics.
• Computed Tomography (CT) CT imaging using SIEMENS Somatom go.top technology to visualize organ density, calcifications, and blood vessels, with CT angiography and perfusion CT for cerebral blood flow visualization. Targeted at patients needing rapid diagnostic imaging or vascular assessment.
• Neuroradiological Brain Check-up Comprehensive preventive examination of the entire nervous system and blood vessels using MRI, including brain morphometry, functional analysis, and vulnerability assessment. Targeted at adults seeking early detection of cerebrovascular disease, cognitive risk assessment, or pre-surgery cerebrovascular evaluation.
• Aneurysm Coiling Endovascular treatment for intracranial aneurysms involving the insertion of platinum coils to block blood flow into the aneurysm sac and prevent rupture. Targeted at patients with diagnosed intracranial aneurysms requiring minimally invasive intervention.
• Stroke Therapy Mechanical recanalization treatment for acute stroke involving catheter-based removal of blood clots to restore cerebral blood flow. Targeted at patients presenting with acute ischemic stroke requiring immediate neurovascular intervention.
• Tinnitus Therapy Endovascular treatment for pulsatile tinnitus that eliminates the vascular source of pulsing sounds in the ears. Targeted at patients with vascular-origin pulsatile tinnitus.
• Stenting and Sclerotherapy Minimally invasive endovascular procedures for treating venous malformations and vascular stenoses. Targeted at patients with neurovascular malformations or stenotic lesions.
• Brain Perfusion Measurement Non-invasive continuous and quantitative measurement of cerebral blood flow using NIRS technology (Luciole medical system), complementing MRI and CT assessment. Targeted at patients needing detailed brain perfusion data alongside structural imaging.
• Second Opinion Consultation Expert neuroradiological consultation for patients seeking second opinions on neurological conditions, including aneurysm assessment and treatment options. Targeted at patients wanting independent expert evaluation of prior imaging or diagnoses.
• Image-Guided Infiltrations Outpatient image-guided pain therapy procedures performed under CT or MRI guidance for targeted pain treatment. Targeted at patients requiring precision-guided minimally invasive pain therapy.

Quantifiable outcome

• Approximately 50% of incidental aneurysm findings are enrolled for treatment using the institution's stability assessment methodology
• +3 more outcomes

Named customers2 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Ten partnerships are on record, tiered minor and core.

• EFMINT (European Foundation of Minimally Invasive Neurological Therapies)minorStrategic or Co-development Partner · 1 January 2013European Foundation for minimally invasive neurological therapies. Co-founded by Prof. Dr. med. Daniel Rüfenacht in 2013.
• ESMINT (European Society of Minimally Invasive Neurological Therapies)minorStrategic or Co-development Partner · 1 January 2011European Society for minimally invasive neurological therapies. Co-founded by Prof. Dr. med. Daniel Rüfenacht in 2011.
• Swiss Clinical Neuro Sciences Institute (SCNSI)coreStrategic or Co-development PartnerSNRI is part of the Swiss Clinical Neuro Sciences Institute (SCNSI), an unprecedented partnership for neuroscience specialists dedicated to patient well-being. SCNSI provides interdisciplinary neuroscience collaboration including neurology, epileptology, neuropsychology, neuroradiology, neurosurgery, and radiosurgery under one roof.
• Swiss Neuro Radiosurgery Center (SNRC)minorStrategic or Co-development PartnerCollaboration for intracranial radiosurgery using high-precision, innovative technology. Part of the SCNSI network of neuroscience institutes.
• Swiss Neuro & Headache Institute (SNHI)minorStrategic or Co-development PartnerPartnership for headache and neurological condition services. Part of the SCNSI network.
• Hirslanden CliniccoreStrategic or Co-development PartnerPartnership for inpatient neuroradiological diagnostics and interventions. SNRI provides specialist consultation and performance of stationary diagnostic examinations and technology-guided treatments at Hirslanden Clinic.
• Zurich Epilepsy InstituteminorStrategic or Co-development PartnerSpecialized diagnostics and consultation in epileptology and EEG. Part of the SCNSI network.
• NeurosonominorStrategic or Co-development PartnerPractice for neurological vascular diagnostics and clinical neurophysiology at SCNSI. Collaboration on stroke prevention and patient care.
• Swiss Neuro-FoundationminorStrategic or Co-development PartnerSwiss Neuro Foundation under federal foundation supervision. Co-founded by Prof. Rüfenacht.
• CABMM (Center of Applied Biotechnology and Molecular Medicine), University of ZurichminorStrategic or Co-development PartnerCompetence center for applied biotechnology and molecular medicine. Preclinical research collaboration including work on intracranial aneurysm disease understanding.

Scale indicators5 records

Recent moves7 records

Expansion highlights5 records

Regional players

• Universitätsspital Zürich (University Hospital Zurich): Academic medical center in Zürich with a full neuroradiology department. Regional incumbent — provides overlapping MRI/CT diagnostic and interventional neuroradiology in the same Zürich market, with academic research capability and broader insurance coverage that competes for both patients and referring physicians.
• Hirslanden Klinik: Swiss private hospital group where SNRI performs its inpatient interventions. Strategic partner and regional comparator — hosts SNRI's inpatient work and operates its own broader radiology services in the same Zürich market.

Others

• Cerenovus (Johnson & Johnson MedTech): Neurovascular intervention device manufacturer (aneurysm coils, flow diverters, stroke thrombectomy). Others — adjacent supplier of the devices SNRI uses for aneurysm coiling and stroke therapy; comparable only as part of the broader neurovascular intervention ecosystem.
• Penumbra, Inc. Medical device company specializing in stroke thrombectomy and neurovascular intervention tools. Others — adjacent supplier enabling SNRI's mechanical recanalization stroke therapy; not a direct competitor but thematically connected via the neurovascular intervention category.

Broad incumbents

• Mednax (now Pediatrix Medical Group): Large physician-led medical group historically including radiology services. Broad incumbent — operates physician-staffed diagnostic practices with similar referral-driven model, but serves much broader medical specialties and geographies.
• RadNet: Largest US outpatient imaging network with 350+ centers. Broad incumbent — comparable outpatient MRI/CT imaging center model serving referring physicians and self-pay patients, but general radiology rather than neuroradiology specialty.
• Affidea: One of Europe's largest outpatient diagnostic imaging and radiotherapy providers operating across 14+ countries. Broad incumbent — overlapping MRI/CT imaging capabilities for similar patient populations, but operates at scale across many modalities and geographies rather than specializing in neuroradiology.
• I-MED Radiology Network: Large diagnostic imaging network with hundreds of clinics across Australia and Europe. Broad incumbent — provides MRI/CT imaging services to referring physicians and patients on a similar fee-for-service model, but at multi-modality scale rather than neuro specialty focus.

Direct peers

• Amen Clinics: US-based chain specializing in brain-focused SPECT imaging and preventive brain health assessments. Direct peer — both operate boutique diagnostic imaging practices targeting preventive brain evaluation for self-referred patients, with similar premium / direct-to-consumer positioning in neuroradiology.
• CereScan: Specialty neuroimaging provider offering quantitative brain SPECT and PET imaging for psychiatric and neurological conditions. Direct peer — comparable boutique neuroimaging service model focused on brain diagnostics, second opinions, and concierge patient experience.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/snri-%E2%80%93-swiss-neuro-radiology-institute

Revenue estimate

Valuation estimate

Number of profiles

Profiles11 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SNRI – Swiss Neuro Radiology Institute